No
|
PY No |
Program Requirements
|
1
|
ÜPY1
|
To raise creative individuals who are able to think critically and solve problems, constantly upgrade themselves in personal and professional fields, are environmentally conscious, respect diversity, and who use their knowledge and skills for the benefit of humanity and the country
|
2
|
ÜPY2
|
To carry out qualified interdisciplinary research that contributes to science and art at a universal level, respecting ethical values, on the path to becoming an innovative university
|
3
|
ÜPY3
|
Being the first university of the Republic, with the awareness of social responsibility, it provides services that are sensitive to the problems of the country, considerate the public interest, and contribute to the development and development of the country and the city in which it lives, as an employee of the kitchen of ideas.
|
4
|
BPY1
|
|
4
|
BPY1
|
|
4
|
BPY1
|
Understands clinical indications of advanced therapy medicinal products worlwide.
|
4
|
BPY1
|
Conceives the multidisciplinary interaction of stem cells and regenerative medicine.
|
4
|
BPY1
|
Makes use of scientific methods and techniques to evaluate and resolve emerging problems in the field of stem cells and regenerative medicine.
|
5
|
BPY2
|
Conceives regulatory framework and fundamental approach regarding tissue and cell banking, clinical use of cellular therapies, bioethics and personallized medicine.
|
5
|
BPY2
|
Clinically assesses the patient's suitability for treatment.
|
5
|
BPY2
|
Gains knowledge on national and international policies related to regenerative medicine.
|
5
|
BPY2
|
Makes use of a well-known method, designs and performs an independent research model.
|
5
|
BPY2
|
Earns knowlegde on concepts and implementation dealing with stem cells and regenerative medicine.
|
5
|
BPY2
|
|
5
|
BPY2
|
Develops one's ideas on stem cells and regenerative medicine to the level of expertise.
|
5
|
BPY2
|
|
6
|
PY1
|
|
6
|
PY1
|
Plans and implements common studies in the partnership of universities, govenrmental organizations and the private sector in the correlation of stem cells, regenerative medicine and healthcare.
|
7
|
PY2
|
|
8
|
PY3
|
|
9
|
PY4
|
|
10
|
PY5
|
|
11
|
PY6
|
|
12
|
PY7
|
|
13
|
PY8
|
|
14
|
PY9
|
|
15
|
PY10
|
|
16
|
PY11
|
|
17
|
PY12
|
|
18
|
PY13
|
|
19
|
PY14
|
|
20
|
PY15
|
|